Thu, February 29, 2024
Wed, February 28, 2024
Tue, February 27, 2024

Oren Livnat Maintained (TARS) at Strong Buy with Increased Target to $57 on, Feb 28th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-57-on-feb-28th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Oren Livnat of HC Wainwright & Co., Maintained "Tarsus Pharmaceuticals, Inc." (TARS) at Strong Buy with Increased Target from $50 to $57 on, Feb 28th, 2024.

Oren has made no other calls on TARS in the last 4 months.



There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, all agrees with Oren's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $19 on, Monday, November 20th, 2023

Publication Contributing Sources